Скачать или смотреть World-leading Non-drug Treatment for Dementia

In this episode of The Purposeful Strategist, Belden Menkus speaks with Devika Wood, CEO of Brain +, a certified health tech provider pioneering Ayla, a digital Cognitive Simulation Therapy (CST), the world-leading non-drug treatment for dementia.


 Together, they explore what it takes to scale a mission-led innovation in a high-regulation, emotionally charged sector – and how strategy, purpose, and commercial realities intersect.


In their conversation, they discuss:


·      Why CST’s inclusion in NICE guidelines opened the door to wide-scale adoption – and what challenges remain.


·      How Devika and the Brain+ team are deploying CST through care homes, upskilling staff, and laying the groundwork for NHS integration.


·      The struggles and rewards of staying mission-based as a publicly listed company.


·      The emotional and ethical responsibilities of working in dementia care.


·      The hard work of refining strategy, testing what language resonates, and building trust at every level.